Product Description
SARS-CoV-2 Spike RBD Antibody [2165] (Biotin) | 10-053 | ProSci
Host: N/A
Reactivity: Virus
Homology: N/A
Immunogen: Sequenced from human survivors of COVID-19 (SARS-CoV-2) . The spike RBD is expressed on the surface of SARS-CoV-2.
Research Area: Infectious Disease, COVID-19
Tested Application: E, IHC
Application: ELISA (Quality Tested by ProSci) ; IHC (Other applications as reported in literature)
Specificiy: Anti-SARS-CoV-2 Spike RBD-Biotin, clone 2165, specifically targets an epitope on the SARS-CoV-2 spike protein receptor-binding domain (RBD) . This antibody does not cross-react with the N-terminal domain (NTD) of the spike protein or the RBD of SARS-CoV.
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: N/A
Clonality: Recombinant Monoclonal
Clone: 2165
Isotype: Human IgG1
Conjugate: biotin
Physical State: Liquid
Buffer: This biotinylated monoclonal antibody is formulated in 0.01 M phosphate buffered saline (PBS) pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Concentration: 0.5 mg/ml
Storage Condition: This biotinylated monoclonal antibody is stable when stored at 2-8˚ C. Do not freeze.
Alternate Name: SARS-CoV-2 Spike RBD Antibody, Receptor Binding Domain Monoclonal Antibody
User Note: 43740568
BACKGROUND: N/A